Research graph
References from Comparative outcomes of advanced medical rescue therapies in steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Cortisone in ulcerative colitis: final report on a therapeutic trial
10.1159/000199983 · 1955 · External reference
Review article: updated management of acute severe ulcerative colitis—from steroids to novel medical strategies
10.1002/ueg2.12442 · 2023 · External reference
ACG Clinical Guideline Update: ulcerative colitis in adults
10.14309/ajg.0000000000003463 · 2025 · External reference
ECCO guidelines on therapeutics in ulcerative colitis: medical treatment
10.1093/ecco-jcc/jjab178 · 2022 · External reference
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
10.1016/s0140-6736(12)61084-8 · 2012 · External reference
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
10.1016/s2468-1253(16)30003-6 · 2016 · External reference
Ciclosporin or infliximab as rescue therapy in acute glucocorticosteroid-refractory ulcerative colitis: systematic review and network meta-analysis
10.1093/ecco-jcc/jjaa226 · 2021 · External reference
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
10.1016/s2468-1253(24)00200-0 · 2024 · External reference
Tofacitinib for biologic-experienced hospitalized patients with acute severe ulcerative colitis: a retrospective case-control study
10.1016/j.cgh.2021.05.038 · 2021 · External reference
Comparative effectiveness of tofacitinib vs upadacitinib for the treatment of acute severe ulcerative colitis
10.1016/j.cgh.2025.07.025 · 2026 · External reference
Rescue therapies for steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis
10.1093/ecco-jcc/jjae111 · 2024 · External reference
Unresolved reference
External reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.31222/osf.io/v7gm2 · 2021 · External reference
Rayyan—a web and mobile app for systematic reviews
10.1186/s13643-016-0384-4 · 2016 · External reference
RoB 2: a revised tool for assessing risk of bias in randomised trials
10.1136/bmj.l4898 · 2019 · External reference
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
10.1136/bmj.i4919 · 2016 · External reference
Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments
10.1002/jrsm.1411 · 2021 · External reference
Bias in meta-analysis detected by a simple, graphical test
10.1136/bmj.315.7109.629 · 1997 · External reference
Fixed- and random-effects models
10.1007/978-1-0716-1566-9_3 · 2022 · External reference
Estimating the sample mean and standard deviation from the sample size, median, range, and/or interquartile range
10.1186/1471-2288-14-135 · 2014 · External reference
Standard deviations and standard errors
10.1136/bmj.331.7521.903 · 2005 · External reference
10.1002/9781119536604
10.1002/9781119536604 · 2019 · External reference
Meta-analytic procedures for combining studies with multiple effect sizes
10.1037/0033-2909.99.3.400 · 1986 · External reference
How to perform a meta-analysis with R: a practical tutorial
10.1136/ebmental-2019-300117 · 2019 · External reference
Measuring inconsistency in meta-analyses
10.1136/bmj.327.7414.557 · 2003 · External reference
Undertaking network meta-analyses
2024 · External reference
Ranking treatments in frequentist network meta-analysis works without resampling methods
10.1186/s12874-015-0060-8 · 2015 · External reference
High-dose infliximab rescue therapy for hospitalized acute severe ulcerative colitis does not improve colectomy-free survival
10.1007/s10620-018-5358-z · 2019 · External reference
Predicting response after infliximab salvage in acute severe ulcerative colitis
10.1111/jgh.14072 · 2018 · External reference
Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs infliximab
10.1111/apt.12375 · 2013 · External reference
Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis
10.1111/j.1440-1746.2011.06958.x · 2012 · External reference
An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis
10.1016/j.cgh.2014.07.041 · 2015 · External reference
Infliximab versus cyclosporine treatment for severe corticosteroid-refractory ulcerative colitis: a Korean, retrospective, single-center study
10.5009/gnl14120 · 2015 · External reference
Comparison of accelerated and standard infliximab induction regimens in acute severe ulcerative colitis using propensity score analysis: a retrospective multicenter study in China
10.1093/gastro/goae051 · 2024 · External reference
Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study
10.1016/j.crohns.2011.11.021 · 2012 · External reference
Early infliximab rescue therapy is associated with reduced length of stay in patients with acute severe ulcerative colitis
10.1186/s12876-026-04847-w · 2026 · External reference
Long-term comparative efficacy of cyclosporine- or infliximab-based strategies for the management of steroid-refractory ulcerative colitis attacks
10.1097/mib.0000000000000101 · 2014 · External reference
Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis
10.1111/jgh.15508 · 2021 · External reference
Comparison of tacrolimus and infliximab for acute severe ulcerative colitis in hospitalized adults: a retrospective study
10.1111/1751-2980.70055 · 2026 · External reference
Hypoalbuminemia and bandemia predict failure of infliximab rescue therapy in acute severe ulcerative colitis
10.1007/s10620-020-06177-7 · 2021 · External reference
Cyclosporine in severe ulcerative colitis refractory to steroid therapy
10.1056/nejm199406303302601 · 1994 · External reference
Systematic review and meta-analysis: infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids
10.1038/ajg.2016.7 · 2016 · External reference
10.1002/9781119536604
10.1002/9781119536604 · ExternalCitation · doi-reference
Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments
10.1002/jrsm.1411 · ExternalCitation · doi-reference
Review article: updated management of acute severe ulcerative colitis—from steroids to novel medical strategies
10.1002/ueg2.12442 · ExternalCitation · doi-reference
Fixed- and random-effects models
10.1007/978-1-0716-1566-9_3 · ExternalCitation · doi-reference
High-dose infliximab rescue therapy for hospitalized acute severe ulcerative colitis does not improve colectomy-free survival
10.1007/s10620-018-5358-z · ExternalCitation · doi-reference
Hypoalbuminemia and bandemia predict failure of infliximab rescue therapy in acute severe ulcerative colitis
10.1007/s10620-020-06177-7 · ExternalCitation · doi-reference
An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis
10.1016/j.cgh.2014.07.041 · ExternalCitation · doi-reference
Tofacitinib for biologic-experienced hospitalized patients with acute severe ulcerative colitis: a retrospective case-control study
10.1016/j.cgh.2021.05.038 · ExternalCitation · doi-reference
Comparative effectiveness of tofacitinib vs upadacitinib for the treatment of acute severe ulcerative colitis
10.1016/j.cgh.2025.07.025 · ExternalCitation · doi-reference
Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study
10.1016/j.crohns.2011.11.021 · ExternalCitation · doi-reference
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
10.1016/s0140-6736(12)61084-8 · ExternalCitation · doi-reference
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
10.1016/s2468-1253(16)30003-6 · ExternalCitation · doi-reference
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
10.1016/s2468-1253(24)00200-0 · ExternalCitation · doi-reference
Meta-analytic procedures for combining studies with multiple effect sizes
10.1037/0033-2909.99.3.400 · ExternalCitation · doi-reference
Systematic review and meta-analysis: infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids
10.1038/ajg.2016.7 · ExternalCitation · doi-reference
Cyclosporine in severe ulcerative colitis refractory to steroid therapy
10.1056/nejm199406303302601 · ExternalCitation · doi-reference
Ciclosporin or infliximab as rescue therapy in acute glucocorticosteroid-refractory ulcerative colitis: systematic review and network meta-analysis
10.1093/ecco-jcc/jjaa226 · ExternalCitation · doi-reference
ECCO guidelines on therapeutics in ulcerative colitis: medical treatment
10.1093/ecco-jcc/jjab178 · ExternalCitation · doi-reference
Rescue therapies for steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis
10.1093/ecco-jcc/jjae111 · ExternalCitation · doi-reference
Comparison of accelerated and standard infliximab induction regimens in acute severe ulcerative colitis using propensity score analysis: a retrospective multicenter study in China
10.1093/gastro/goae051 · ExternalCitation · doi-reference
Long-term comparative efficacy of cyclosporine- or infliximab-based strategies for the management of steroid-refractory ulcerative colitis attacks
10.1097/mib.0000000000000101 · ExternalCitation · doi-reference
Comparison of tacrolimus and infliximab for acute severe ulcerative colitis in hospitalized adults: a retrospective study
10.1111/1751-2980.70055 · ExternalCitation · doi-reference
Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs infliximab
10.1111/apt.12375 · ExternalCitation · doi-reference
Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis
10.1111/j.1440-1746.2011.06958.x · ExternalCitation · doi-reference
Predicting response after infliximab salvage in acute severe ulcerative colitis
10.1111/jgh.14072 · ExternalCitation · doi-reference
Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis
10.1111/jgh.15508 · ExternalCitation · doi-reference
Bias in meta-analysis detected by a simple, graphical test
10.1136/bmj.315.7109.629 · ExternalCitation · doi-reference
Measuring inconsistency in meta-analyses
10.1136/bmj.327.7414.557 · ExternalCitation · doi-reference
Standard deviations and standard errors
10.1136/bmj.331.7521.903 · ExternalCitation · doi-reference
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
10.1136/bmj.i4919 · ExternalCitation · doi-reference
RoB 2: a revised tool for assessing risk of bias in randomised trials
10.1136/bmj.l4898 · ExternalCitation · doi-reference
How to perform a meta-analysis with R: a practical tutorial
10.1136/ebmental-2019-300117 · ExternalCitation · doi-reference
Cortisone in ulcerative colitis: final report on a therapeutic trial
10.1159/000199983 · ExternalCitation · doi-reference
Estimating the sample mean and standard deviation from the sample size, median, range, and/or interquartile range
10.1186/1471-2288-14-135 · ExternalCitation · doi-reference
Ranking treatments in frequentist network meta-analysis works without resampling methods
10.1186/s12874-015-0060-8 · ExternalCitation · doi-reference
Early infliximab rescue therapy is associated with reduced length of stay in patients with acute severe ulcerative colitis
10.1186/s12876-026-04847-w · ExternalCitation · doi-reference
Rayyan—a web and mobile app for systematic reviews
10.1186/s13643-016-0384-4 · ExternalCitation · doi-reference
ACG Clinical Guideline Update: ulcerative colitis in adults
10.14309/ajg.0000000000003463 · ExternalCitation · doi-reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.31222/osf.io/v7gm2 · ExternalCitation · doi-reference
Infliximab versus cyclosporine treatment for severe corticosteroid-refractory ulcerative colitis: a Korean, retrospective, single-center study
10.5009/gnl14120 · ExternalCitation · doi-reference
